Belyea to step down as Metabolic CEO
By Renate Krelle
Thursday, 13 January, 2005
Thursday, 13 January, 2005
Obesity drug-developer Metabolic (ASX:MBP) announced today that the company is searching for a new CEO and that when an appointment is made, founding CEO Chris Belyea will move into a "scientific and technical" role within the company.
The company said Belyea had expressed his desire to relinquish the CEO role in August 2004. Board chairman Arthur Emmett has since been undertaking the search for a new CEO.
Related News
$780m Sydney Biomedical Accelerator gains its founding Executive Director
Professor Victoria Cogger has been appointed as founding Executive Director of the Sydney...
Portable point-of-care test detects four common STIs in under an hour
Australian researchers have developed a portable point-of-care test that detects four common...
AusBiotech and Proto Axiom partner on investor-focused life sciences programs
AusBiotech and Proto Axiom have announced a partnership to strengthen national coordination...
